Animal Health Solution - a Covetrus magazine for veterinary professionals
Issue link: https://www.e-digitaleditions.com/i/1369858
Learn more at NexGardClinic.com *Assessment was conducted by IDEXX® and leveraged veterinary clinic PIMS transaction level data for 2019. This analysis included data from approximately 7,000 U.S. clinics that had consistent data from 2017 to 2019. To be included, patients needed to have at least one parasiticide transaction in the baseline year (2018). The analysis was limited to loyal patients, where loyalty was defined as having one flea/tick control brand during the full three-year period. The average number of months of NexGard purchased per year was 6.64, compared to 6.69 for BRAVECTO. This analysis overestimates the duration of efficacy for BRAVECTO. For comparison purposes, each BRAVECTO chew was assessed as providing three months of flea & tick protection versus the labeled 12-week coverage for fleas and three species of ticks, and 8-week coverage for Lone Star ticks. 1. Data on file at Boehringer Ingelheim. 2. Data on file at IDEXX Laboratories, Inc. Westbrook, Maine USA. • NexGard® (afoxolaner) is the only chew FDA-approved to prevent Lyme infections by killing black-legged ticks. • It's safe for puppies as young as 8 weeks, weighing as little as 4 pounds. • The savory, beef-flavored chew was designed with compliance in mind: • NexGard is a leader in average number of months of flea and tick control purchased per patient per year. *2 • More NexGard users purchased a full 12 months of flea and tick protection than users of any other flea and tick chew. *2 IMPORTANT SAFETY INFORMATION: NexGard is for use in dogs only. The most frequently reported adverse reactions include vomiting, pruritus, lethargy, diarrhea and lack of appetite. The safe use of NexGard in pregnant, breeding, or lactating dogs has not been evaluated. Use with caution in dogs with a history of seizures or neurologic disorders. For more information, see the full prescribing information or visit NexGardClinic.com. In Clinic. At Home. Thank you for trusting NexGard® (afoxolaner) over 270 million times. 1 NexGard® is a registered trademark and FRONTLINE VET LABS™ is a trademark of the Boehringer Ingelheim Group. All other trademarks are property of their respective owners. ©2021 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All rights reserved. US-PET-0902-2020